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Ossiﬁcation of the posterior longitudinal ligament (OPLL) of the spine is a subset of “bone-forming” diseases,
characterized by ectopic ossiﬁcation in the spinal ligaments. OPLL is a common disorder among elderly populations
in eastern Asia and is the leading cause of spinal myelopathy in Japan. We performed a genomewide linkage study
with 142 affected sib pairs, to identify genetic loci related to OPLL. In multipoint linkage analysis using GENE-
HUNTER-PLUS, evidence of linkage to OPLL was detected on chromosomes 1p, 6p, 11q, 14q, 16q, and 21q.
The best evidence of linkage was detected near D21S1903 on chromosome 21q22.3 (maximum ); there-Z p 3.97lr
fore, the linkage region was extensively investigated for linkage disequilibriumwith single-nucleotidepolymorphisms
(SNPs) covering 20 Mb. One hundred ﬁfty positional candidate genes lie in the region, and 600 gene-based SNPs
were genotyped. There were positive allelic associations with seven genes ( ) in 280 patients and 210 controls,P ! .01
and four of the seven genes were clustered within a region of 750 kb, ∼1.2 Mb telomeric to D21S1903. Extensive
linkage disequilibrium and association studies of the four genes indicated that SNPs in the collagen 6A1 gene
(COL6A1) were strongly associated with OPLL ( for the SNP in intron 32 [529]). Haplotype analysisPp .000003
with three SNPs in COL6A1 gave a single-point P value of .0000007. Identiﬁcation of the locus of susceptibility
to OPLL by genomewide linkage and linkage disequilibrium studies permits us to investigate the pathogenesis of
the disease, which may lead to the development of novel therapeutic tools.
Introduction
Ossiﬁcation of the posterior longitudinal ligament (OPLL
[MIM 602475]) of the spine was ﬁrst reported in Japan
and is a common disorder among Japanese and other
Asian populations (Matsunaga and Sakou 1997). The
incidence of OPLL in Japan is 2%–4% of the general
population 130 years of age, with a male predominance
of 2:1 (Matsunaga and Sakou 1997). Heterotopic os-
siﬁcation of the spinal ligament is the speciﬁc feature of
OPLL that causes compression of the spinal cord and
leads to various degrees of myelopathy. Typical symp-
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toms of OPLL are sensory and motor disturbance of the
upper and lower extremities, abnormal reﬂexes, hyper-
responsive deep reﬂexes, and bladder-bowel dysfunction.
Various degrees of dysfunction, such as precise action
and gait disturbance, lead to the restriction of activities
involved in daily living and the deterioration of quality
of life. Multiple etiologies for OPLL need to be consid-
ered because of the late-onset nature of the disease; how-
ever, the disease is, to some extent, genetically deter-
mined, as is demonstrated by the classic epidemiologic
study and by the estimated relative risk of 10 for siblings
of affected individuals (Terayama 1989; Sakou et al.
1991). OPLL is a high-bone-mass disease (or systemic
hyperostosis), and patients with OPLL, especially women
160 years of age, have increased systemic bone mineral
density (Yamauchi et al. 1999). Another ossiﬁcation dis-
order, diffuse idiopathic skeletal hyperostosis (DISH),
appears to be related to OPLL (Trojan et al. 1992). DISH
is a common skeletal disease in middle-aged and elderly
patients (with frequencies in individuals 150 years of
age of 25% in men and 15% in women) in Western
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countries. The disease is characterized by ligamentous
ossiﬁcation of the anterolateral aspect of the spinal col-
umn, sometimes leading to bony ankylosis (Resnick et
al. 1978). The extent of overlap of OPLL with DISH is
uncertain; however, the pathophysiological mechanism
of DISH may be similar to that of OPLL (Trojan et al.
1992; Weinfeld et al. 1997).
Because genetic factors appear to have a crucial role
inOPLL, the use ofmolecular genetic studies is important
to the understanding of the molecular etiologies of OPLL
and will lead to the development of new therapeutics.
Elsewhere, we reported linkage evidence in the HLA
region of chromosome 6 in 91 affected sib pairs and
identiﬁed the collagen 11A2 gene (COL11A2 [MIM
120290]) as a possible candidate (Koga et al. 1998). Al-
lelic association studies between OPLL and molecular
variants in COL11A2 demonstrated that a nucleotide
substitution at intron 6 (4), a TrA substitution, is sig-
niﬁcantly associated with OPLL, and the functional var-
iant results in altered splicing, which is protective in the
pathogenesis of OPLL (Maeda et al. 2001). Nakamura
et al. (1999) reported that the nucleotide pyrophospha-
tase gene (NPPS [MIM 173335]), which has been iden-
tiﬁed as causal in a mouse model of OPLL (Okawa et
al. 1998), is also associated with OPLL.
To understand the whole picture of OPLL suscepti-
bility, we conducted a genomewide linkage study in 70
Japanese nuclear families, comprising 169 subjects and
142 affected sib pairs. At least six potential loci were
linked to OPLL, with evidence for linkage being par-
ticularly strong on chromosome 21. Linkage analysis
alone cannot provide the necessary resolution to identify
the underlying genee, especially in complex diseases.
Fine mapping of the linked regions can be attempted
using linkage disequilibrium analysis with SNPs. Be-
cause a recent study of asthma susceptibility found that
the 1-LOD decrease in the support interval of the link-
age likely contains the susceptibility locus (Van Eerde-
wegh et al. 2002), the interval of the 1-LOD decrease
on chromosome 21, ∼20 cM, was extensively studied
by use of linkage disequilibrium mapping to pinpoint
the locus of OPLL. When 600 SNPs of 150 genes were
screened, signiﬁcant associations were revealed between
OPLL and molecular variants in collagen 6A1 (COL6A1
[MIM 120220]). The disease-related linkage disequilib-
rium was also assessed by haplotype-based association
study.
Subjects and Methods
Disease Criteria and Subjects
The ethics committees of Hirosaki University and
Kagoshima University approved the study, and all pa-
tients gave written informed consent. OPLL was diag-
nosed by the observation of ectopic bone formation in
the posterior longitudinal ligament during x-ray or com-
puted tomography examinations of the cervical, tho-
racic, or lumbar portions of the spine. The disease status
of OPLL in radiograms was classiﬁed into four types,
according to criteria of the Investigation Committee on
the Ossiﬁcation of the Spinal Ligaments, the Ministry
of Health, Labor, and Welfare, Japan: (i) segmental, (ii)
continuous, (iii) mixed, and (iv) localized, circumscribed,
or bridged. All four types of OPLL were examined in
the present study.
The siblings of patients with OPLL were screened for
excessive spinal bone formation by x-ray examination,
and affected siblings, including asymptomatic individ-
uals, were recruited (Koga et al. 1998; Furushima et al.
2002). Samples for DNA analysis were collected from
a total 142 affected sib pairs from 70 Japanese families;
98 pairs were from Kagoshima, 40 pairs from Hirosaki,
2 pairs from Asahikawa, and 1 pair each from Waka-
yama and Okinawa. The family structure was as follows:
51 affected pairs, 12 affected trios, 5 affected quartets,
1 affected quintet, and 1 affected sextet. The affected
siblings included 76 women and 93 men. For the allelic
association study, 342 unrelated patients with OPLL (73
familial cases, including 70 probands used for linkage
study and 269 sporadic cases) and 298 unrelated sub-
jects without OPLL were recruited in Kagoshima and
Hirosaki. All the subjects without OPLL were 160 years
of age and had no signs of spinal ossiﬁcation when ex-
amined by standard x-ray methods, thereby excluding
excluding most unmanifested diseases.
Microsatellite Genotyping
Multiplex ﬂuorescent genotyping was performed us-
ing ABI PRISM linkage mapping set version 2 (Applied
Biosystems). Because several markers were not poly-
morphic in the Japanese population (Ikari et al. 2001),
a set of 47 markers obtained from the Genome Database
were added to the original set to ﬁll in the gap (Onda
et al. 2001). An extra sequence was attached to the 5′
end of the reverse primer to promote nontemplated ad-
dition of adenine for accurate genotyping (Brownstein
et al. 1996). Four markers (D6S446, D9S1678, D17S938,
and DXS8067) generated incomplete data on the ﬁrst
round of genotyping and were excluded from further
analysis. Marker positions (in Kosambi centimorgans)
were obtained from the Marshﬁeld Medical Research
Foundation (Broman et al. 1998). For chromosome
21, which demonstrated signiﬁcant linkage when the
framework marker set was used, markers were added
for dense mapping that covered !5 cM in the region
(markers D21S1904, D21S1884, D21S1258, D21S262,
D21S1900, D21S1893, D21S1411, and D21S1903).
Microsatellite genotyping was performed as described
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Table 1
Genes Showing Positive Associations ( ) with OPLLP ! .01
on Chromosome 21
GENE and
dbSNP ID
ALLELE FREQUENCY
IN SUBJECTS
x2
(1 df) P
With
OPLL
( )np 280
Without
OPLL
( )np 210
PRKCBP2:
rs762178 .184 .123 6.73 .0095
DSCR1:
JST022042 .041 .095 8.05 .0046
CBR1:
rs20572 .220 .137 10.85 .0010
COL18A1:
JST016803 .345 .454 11.31 .0007
JST016805 .329 .441 12.25 .0005
JST016806 .336 .442 10.64 .0011
PCBP3:
rs2839036 .411 .312 12.75 .0004
rs2839037 .106 .043 15.16 .0001
rs395418 .239 .167 9.19 .0020
COL6A1:
JST003751 .402 .310 11.23 .0008
JST016807 .124 .063 13.44 .0002
JST016808 .440 .329 16.27 .00005
JST106809 .439 .327 15.95 .00006
COL6A2:
rs914246 .341 .261 8.18 .004
elsewhere (Furushima et al. 2002). All marker genotypes
were checked for Mendelian inheritance, using the
Checkfam program (Saito et al. 2002), and genotyping
inconsistencies were corrected.
Affected-Sib-Pair Linkage Analysis
GENEHUNTER-PLUS (Kong and Cox 1997) and
GENEHUNTER 2.1 (Kruglyak et al. 1996) were used
to analyze the data on affected sib pairs. Multipoint
analysis of the data from the genomewide scan and from
the ﬁne mapping was performed by weighting each
family equally with GENEHUNTER-PLUS, a modi-
ﬁed version of GENEHUNTER. GENEHUNTER-PLUS
assumes a linear model for risk and thus provides more-
accurate calculations of the variance than does the orig-
inal program. GENEHUNTER 2.1 was used for esti-
mates of the mean proportion of alleles shared identical
by descent (IBD) and for exclusion mapping. The link-
age exclusion was set at a LOD score of 2. GENE-
HUNTER 2.1 was also used to calculate information
content. Allele frequencies of microsatellite markers
were estimated in 64 unrelated Japanese subjects (Ikari
et al. 2001). For dense mapping on chromosome 21,
allele frequencies of the markers were estimated with 70
probands, to perform more stringent linkage analysis.
SNP Genotyping
SNPs were obtained from the two public databases:
National Center for Biotechnology Information dbSNP
and Institute of Medical Science–Japan Science and Tech-
nology Corporation database of Japanese SNPs. Gene-
based SNPs were selected at 3- to 10-kb intervals to cover
the gene. Twelve subjects with OPLL were genotyped for
each SNP, to conﬁrm frequencies of minor alleles, and
SNPs with minor allele frequencies 10.08 were subjected
to further analyses. SNPs in the coding region or regu-
latory region that may directly affect gene function were
given priority, regardless of the minor allele frequencies.
PCR analysis was performed with a standard protocol,
except that a biotin-labeled primer was used when the
pyrosequencing method was applied. SNPs were geno-
typed using either the pyrosequencingmethod (a real-time
pyrophosphate DNA sequencing, on a PSQ96 Instrument
[Pyrosequencing]) or direct sequencing (using BigDye ter-
minator cycle sequencing on an ABI PRISM 3700 DNA
analyzer [Applied Biosystems]).
Other Statistical Analyses
Allelic frequencies of polymorphisms in cases and con-
trols were compared using a contingency x2 test. Hap-
lotype frequencies for multiple loci were estimated using
the expectation-maximization method with the Arlequin
program, which is available at the Arlequin Web site or
SNPAlyze program (Dynacom). Pairwise LD was esti-
mated as , where x11 is the frequency ofDp x  p q11 1 1
haplotype A1B1, and p1 and q1 are the frequencies of
alleles A1 and B1 at loci A and B, respectively. A stan-
dardized LD coefﬁcient, r, is given by ,1/2D/(p p q q )1 2 1 2
where p2 and q2 are the frequencies of the other alleles
at loci A and B, respectively (Hill and Robertson 1968).
Lewontin’s coefﬁcient, D′, is given by ,′D p D/Dmax
where ) when orD p min(p q ,p q D ! 0 D pmax 1 2 2 1 max
) when (Lewontin 1964).min(p q ,p q D 1 01 1 2 2
Results
Affected-Sib-Pair Linkage Analysis
A total of 70 Japanese families comprising 169 af-
fected subjects and 142 sib pairs were included in the
genome-scan data set. Multipoint Zlr scores for all chro-
mosomes (except the Y chromosome) are displayed in
ﬁgure 1. The region with the most prominent evidence
of linkage was on chromosome 21q22, with a maximum
Zlr score of 3.09 near marker D21S266. In addition to
chromosome 21, ﬁve others—on chromosomes 1p, 6p,
11q, 14q, and 16q—showed evidence of linkage (deﬁned
as ). Because the best evidence of linkage wasZ 1 2.2lr
observed with markers on chromosome 21q, high-res-
olution mapping was performed by adding eight mark-
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Table 2
Polymorphisms in COL6A1 and Their Association with OPLL
NUMBER LOCATIONa
NCBI
dbSNP ID
NUCLEOTIDE
SUBSTITUTION
AMINO
ACID
CHANGE
ALLELE FREQUENCY IN SUBJECTS
(NO. OF SUBJECTS)
x2
(dfp1) P
With
OPLL
Without
OPLL
1 Exon1 (5) rs7671 GrC … .323 (314) .262 (284) 5.33 .020
2 Intron 2 (651) rs2072699 GrA … .217 (92) .215 (86) .003 .958
3 Intron 2 (758) Non-dbSNP TrC … .352 (91) .238 (86) 5.44 .019
4 Intron 3 (1326) rs760437 CrT … .049 (92) .068 (88) .61 .435
5 Intron 4 (13) rs754507 ArC … .320 (86) .227 (77) 3.48 .062
6 Intron 4 (20) Non-dbSNP GrC … .176 (85) .132 (76) 1.23 .267
7 Intron 4 (37) Non-dbSNP ArG … .203 (64) .089 (62) 6.58 .010
8 Intron 8 (208)b rs2839076 GrC … .123 (312) .087 (281) 4.08 .043
9 Intron 9 (62) Non-dbSNP TrC … .423 (300) .346 (272) 7.27 .007
10 Intron 9 (188) rs2277813 CrG … .174 (290) .133 (267) 3.61 .057
11 Intron 9 (19)b rs2277814 GrA … .051 (89) .084 (89) 1.61 .205
12 Exon 15 (39) rs1980982 TrC Gly/Gly .402 (331) .310 (287) 11.23 .0008
13 Intron 15 (39) Non-dbSNP CrT … .264 (331) .200 (285) 7.06 .008
14 Intron 18 (138)b rs760439 GrA … .031 (81) .085 (59) 3.91 .048
15 Intron 19 (27) rs2850173 CrA … .137 (84) .072 (83) 3.72 .053
16 Intron 19 (116) rs2075893 TrC … .455 (77) .327 (78) 5.30 .021
17 Intron 19 (361) rs2742071 TrC … .043 (92) .074 (88) 1.51 .219
18 Intron 19 (152)b rs2850174 TrG … .132 (87) .091 (77) 1.39 .238
19 Intron 20 (745) rs2850175 ArC … .133 (338) .077 (297) 10.26 .001
20 Intron 20 (32)b rs2839077 CrT … .417 (333) .340 (296) 8.06 .005
21 Intron 21 (18) rs2276254 ArC … .340 (316) .236 (277) 15.37 .00009
22 Intron 21 (36)b rs2276255 ArG … .076 (79) .026 (76) 3.90 .048
23 Intron 22 (19) rs2276256 GrC … .234 (92) .264 (89) .45 .504
24 Intron 32 (29)b Non-dbSNP TrC … .335 (336) .216 (298) 21.99 .000003
25 Intron 33 (15) rs2236485 GrA … .124 (342) .063 (292) 13.44 .0002
26 Intron 33 (20) rs2236486 ArG … .440 (342) .329 (293) 16.27 .00005
27 Intron 33 (55) rs2236487 ArG … .439 (330) .327 (278) 15.95 .00006
28 Intron 33 (88) rs2236488 CrT … .311 (323) .252 (270) 5.08 .02
29 Exon 35 (85) rs1053312 GrA Arg/His .248 (322) .199 (271) 4.97 .044
30 Exon 35 (203) rs1053315 GrA Ala/Ala .249 (321) .199 (269) 4.24 .040
31 Exon 35 (205) Non-dbSNP CrT Ser/Leu .059 (321) .065 (269) .17 .677
32 Exon 35 (332) rs1053320 CrT Ser/Ser .235 (321) .180 (269) 5.32 .021
a Numbers in parentheses indicate the nucleotide position from the start of exon or intron with two exceptions: exon 1 (5), in which the
number refers to its position from the start codon, and numbers deﬁned in footnote b.
b Numbers in parentheses indicate the distance from the last intronic nucleotide.
ers. The ﬁne mapping on chromosome 21 (ﬁg. 2) in-
dicated that the linkage peak ( ) was closeZ p 3.97lr
to the q terminus near marker D21S1903. The highest
two-point Zlr score (3.69) was detected at D21S1903 on
the q terminus, and the highest IBD sharing of 71%
( ) was observed atZ p 0.04; Z p 0.50; Z p 0.460 1 2
D21S262 on 21q22.
Screening of Genes on the Linkage Region
of Chromosome 21
The best evidence of linkage was detected with mark-
ers on chromosome 21q21; however, the linkage region
( ) spans ∼30 cM, and the 1-LOD decrease inZ 1 2.2lr
the support interval was ∼20 cM and contained 200
genes. To pinpoint the locus for OPLL, linkage dis-
equilibrium analysis was performed using gene-based
SNPs in the region. We ﬁrst genotyped 600 SNPs of 150
genes in the linkage region from 96 selected patients and
96 controls. The selected patients consisted of 73 un-
related patients with family history and 23 patients with
age at onset !45 years. The remaining 50 genes were not
investigated, because there were no SNPs in the database
or SNPs were not polymorphic in Japanese populations.
Allelic association was assessed by x2 analysis with a con-
tingency table. Seventy-four SNPs of 24 genes exhibited
signiﬁcant allelic associations ( ; data not shown).P ! .05
For the second screening, we genotyped the 74 SNPs in
an expanded number of patients with OPLL ( )np 280
and in control subjects without OPLL ( ). Thesenp 210
patients included the initial screening sets. Fourteen SNPs
of seven genes had allelic associations ( ) withP ! .01
OPLL (table 1). The most signiﬁcant association with
OPLL was observed with SNPs of COL6A1, which is
located 1.2Mb from the peak linkagemarker,D21S1903.
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Table 3
Estimated Haplotype Frequency in Subjects with and without OPLL
HAPLOTYPEa
FREQUENCY IN SUBJECTS
x2
(df p 1) P
ODDS RATIO
(95% CI)
With
OPLL
(n p 306)
Without
OPLL
(n p 270)
H1 (//) .548 .647 11.64 .0006 .66 (.59–.84)
H2 (//) .297 .172 24.73 .0000007 2.03 (1.76–2.70)
H3 (//) .067 .070 .05 .82 .95 (.75–1.50)
H4 (//) .046 .045 .01 .92 1.03 (.78–1.80)
Othersb .042 .066 2.69 .101 .61 (.48–1.04)
a  p major allele;  p minor allele; the marker order, from left to right, is as follows:
intron 21 (18), intron 32 (29), and intron 33 (20).
b Haplotypes with frequencies !3%.
Because the four genes (COL18A1 [MIM 120328],
PCBP3, COL6A1, and COL6A2 [MIM 120240]) that
showed positive associations with OPLL are clustered
within a 750-kb region in the vicinity of marker
D21S1903, extensive SNP and pairwise linkage disequi-
librium analyses were performed in the region. A total of
92 SNPs were analyzed for linkage disequilibrium struc-
tures in the region (ﬁg. 3). Highly structured linkage dis-
equilibrium blocks, as estimated with theD′ statistic,were
observed; for example, COL18A1 was separated in two
blocks, and the second block included SLC19A1. Because
we genotyped gene-speciﬁc SNPs rather than SNPs in in-
tergenic regions, we could not detect a broad scale of
linkage disequilibrium blocks. The structures of pairwise
linkage disequilibrium blocks were almost identical be-
tween patients and controls. SNPs of COL6A1 that had
the strongest association with OPLL were in a gene-
speciﬁc linkage disequilibrium block; therefore,COL6A1
was examined in more detail as the most likely candidate
gene for OPLL. A total of 32 distinct SNPs—including
the 4 SNPs used for the ﬁrst screening, 25 additional
dbSNPs, and 7 non-dbSNPs identiﬁed by direct sequenc-
ing—were genotyped in all the patients ( ) andnp 342
controls ( ) (table 2). Among 7 SNPs identiﬁed innp 298
the present study, SNP31 at exon 35 led to a nonsynon-
ymous change (serine to leucine), and other changes oc-
curred in introns (table 2). Of 32 SNPs, 21 were statis-
tically associated with OPLL ( ); of these, 4 hadP ! .05
a particularly strong association ( withOPLL;P ! .0001
table 2). The most signiﬁcant allelic association with
OPLL was observed with a TrC substitution at intron
32 (29) ( ; ; ; odds ratio2x p 21.99 dfp 1 Pp .000003
p 1.82 [95% CI p 1.60–2.35]). A TrC substitution at
exon 15 (39), which is a silent substitution, had the
most signiﬁcant association with OPLL among six coding
SNPs ( ; ; ; odds ratio p2x p 11.23 dfp 1 Pp .0008
1.49 [95%CIp 1.33–1.89]). For an explanation of num-
bers in parentheses that follow indications of location, see
footnotes to table 2.
Haplotype Analysis of COL6A1
Because multiple SNPs may act in combination to in-
crease the risk of OPLL, haplotypes were constructed
on the basis of maximum likelihood. Three SNPs in
COL6A1 (intron 21 [18], intron 32 [29], and intron
33 [20]) that had highly signiﬁcant associations with
OPLL and were not in complete linkage disequilibrium
with each other, as estimated using the r measure ( 2r !
; ﬁg. 4), were selected for haplotype analysis (table0.7
3). Estimated haplotype frequencies of the four common
haplotypes (H1–H4) of subjects with OPLL were com-
pared with those of control subjects without OPLL.
There was a signiﬁcant difference in haplotype frequency
between cases and controls: haplotype H2, which com-
prises all the minor alleles at each site, occurred at a
higher frequency in patients with OPLL than in control
subjects ( , , , odds ratio2x p 24.73 dfp 1 Pp .0000007
p 2.03 [95% CI p 1.76–2.70]); and haplotype H1,
which comprises all the common alleles at each site, had
a higher frequency in subjects without OPLL than in
patients with OPLL ( ; ; ;2x p 11.64 dfp 1 Pp .0006
odds ratio p 0.66 [95% CI p 0.59–0.84]). The global
test also gave a statistically signiﬁcant result ( 2x p
; ; ).26.73 dfp 4 Pp .000023
Discussion
The linkage results of the genomewide scan with 142
affected sib pairs revealed that six loci, on chromosomes
1p, 6p, 11q, 14q, 16q, and 21q, confer susceptibility to
OPLL ( ), and the most promising locus was onZ 1 2.2lr
chromosome 21q22 ( ) (ﬁg. 1). Dense map-Z p 3.09lr
ping of chromosome 21 revealed increased evidence of
linkage on 21q22 near D21S1903 ( ) thatZ p 3.97lr
would exceed the threshold of signiﬁcant linkage (ﬁg. 2)
(Lander and Kruglyak 1995). The linkage region was
studied extensively through linkage disequilibriummap-
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ping and haplotype analysis, to narrow the susceptibility
locus of OPLL.
Among ﬁve other susceptibility loci, chromosome 6
was of particular interest because previous studies re-
ported that two candidate genes for OPLL (COL11A2
and NPPS) are on that chromosome (Koga et al. 1998;
Nakamura et al. 1999). In the multipoint linkage study
of chromosome 6, the highest Zlr score (2.22) and the
best IBD sharing (59%; ; ;Z p 0.16 Z p 0.50 Z p0 1 2
) was on 6p21, where COL11A2 is located. On the0.34
other hand, the NPPS locus did not show any evidence
of linkage ( ; mean IBD sharing 50.5%), con-Z p 0.00lr
ﬁrming previous results of a single-point linkage analysis
(Furushima et al. 2002).
The second most signiﬁcant linkage ( ) wasZ p 2.94lr
observed at chromosome 14, indicating that the chro-
mosome 14q region may harbor another responsible
gene. Notably, the linkage region at 14q is the widest
linkage peak throughout the genome (43 cM; Z lr
). Terwilliger et al. (1997) suggest that IBD sharing2.2
would be expected to decline gradually over adjacent
markers when true linkage is present, resulting in a
broad Zlr score distribution. Because the best evidence
of linkage was on chromosome 21, the 14q region was
not pursued in the present study.
The genomewide linkage results indicated the best
evidence of linkage to OPLL on chromosome 21; there-
fore, we proceeded to narrow the locus through a link-
age disequilibrium study. We performed an association
study with ∼600 SNPs of 150 genes covering the 20-
Mb linkage region of chromosome 21q. COL6A1 is the
gene most signiﬁcantly associated with OPLL in the
case-control comparison ( ) and thePp .04–.000003
haplotype analysis ( ) (tables 2 and 3). InPp .0000007
addition, pairwise linkage disequilibrium analysis
revealed that COL6A1 is in the gene-speciﬁc linkage
disequilibrium block (ﬁg. 3). Thus, susceptibility to
OPLL could be accurately pinpointed to the COL6A1
locus. Mutations in the genes that encode collagen
VI subunits (COL6A1, COL6A2, and COL6A3) are
causal of Bethlem myopathy (MIM 158810), a domi-
nant form of myopathy, and Ullrich syndrome (MIM
254090), a recessive form of muscular dystrophy (Jobsis
et al. 1996; Lamande et al. 1998; Pape et al. 1999;
Camacho Vanegas et al. 2001; Scacheri et al. 2002)
characterized by early childhood onset of proximalmus-
cle weakness and contractures of multiple joints (Beth-
lem and Wijngaarden 1976; Mohire et al. 1988). In the
present study, we did not detect any molecular variants
in the key glycine residues of the triple-helix domain
that result in Bethlem myopathy. COL6A1 encodes the
a1 chain of type VI collagen, which is an extracellular
matrix protein consisting of a short central triple helix
ﬂanked by two large globular domains. Because the SNP
(the TrC substitution at intron 32 [29]) that is most
strongly associated with OPLL is near the branch site
of the intron, that SNP may affect the lariat-shaped
structure, thereby causing aberrant splicing.Ourprevious
linkage and association studies identiﬁed COL11A2 as
a candidate for OPLL, and the functional intron 6 (4A)
polymorphism of COL11A2 affects splicing of exon 6
(Koga et al. 1998; Maeda et al. 2001). RT-PCR analyses
of COL6A1 on cultured interspinous ligament cells from
10 patients with OPLL were performed, to study the
splicing variants ofCOL6A1, as described in the analysis
of COL11A2 published elsewhere (Maeda et al. 2001).
Thus far, we have not detected a splicing variant of
COL6A1 due to the intron 32 (29) genotype (data
not shown). The functional impact of the polymor-
phisms of COL6A1 is uncertain, but COL6A1 may
lead to increased bone mass. Two genes (COL6A1 and
COL11A2) encode extracellular matrix proteins, which
may provide a scaffold for osteoblastic or preosteoblastic
cells or chondrocytes that subsequently proceed to mem-
branous or endochondral ossiﬁcation (Zhang and Chen
2000; Gowen et al. 2003). Therefore, molecular variants
of the extracellular proteins may be implicated in the
ectopic ossiﬁcation observed in OPLL.
The etiologies of all complex diseases potentially
involve gene-gene and gene-environment interactions.
In the case of OPLL, interactions of COL6A1 and
COL11A2 must be taken into account in efforts to fur-
ther understand the etiology of the disease. Elucidation
of the molecular etiology of OPLL will lead to the de-
velopment of new therapeutic approaches, not only for
bone-forming diseases but also for diseases of bone loss,
such as osteoporosis.
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